文献速递冠心病血脂与心血管预防

睡眠呼吸暂停与冠状动脉旁路移植术后心血管结局

Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
PubMed 文献 · Heart · 2020-05-18

这项前瞻性队列研究纳入1007例接受非急诊冠状动脉旁路移植术的患者,术前用腕式设备行睡眠监测,睡眠呼吸暂停定义为呼吸暂停低通气指数≥15次/小时,共诊断513例(50.9%)。平均随访2.1年,睡眠呼吸暂停组MACCE粗发生率高于非睡眠呼吸暂停组(2年估计14.7% vs 7.8%,p=0.002),校正混杂因素后睡眠呼吸暂停仍独立预测MACCE(校正HR 1.57;95%CI 1.09–2.25)。

要点

  • CABG术前睡眠呼吸暂停患病率高,1007例中513例(50.9%)符合诊断。
  • 睡眠呼吸暂停与MACCE独立相关,校正后HR 1.57(95%CI 1.09–2.25)。
  • 睡眠呼吸暂停组2年MACCE估计发生率14.7%,高于非睡眠呼吸暂停组7.8%。

核心结论

  • 在接受非急诊冠状动脉旁路移植术的患者中,睡眠呼吸暂停与主要不良心脑血管事件(MACCE)风险升高独立相关。

研究设计与样本

  • 前瞻性队列研究,2013年11月至2018年12月从四家公立医院转诊至三级心脏中心、接受非急诊CABG的患者,术前用腕式Watch-PAT 200设备行夜间睡眠监测。
  • 共1007例完成研究,睡眠呼吸暂停定义为呼吸暂停低通气指数≥15次/小时。

主要发现

  • 1007例中513例(50.9%)诊断睡眠呼吸暂停。
  • 平均随访2.1年,124例发生四组分MACCE,2年累积发生率估计为11.3%。
  • MACCE组分:心源性死亡33例(2.5%)、非致死性心肌梗死42例(3.7%)、非致死性卒中50例(4.9%)、计划外血运重建36例(3.2%)。
  • 睡眠呼吸暂停组MACCE粗发生率高于非睡眠呼吸暂停组(2年估计14.7% vs 7.8%;p=0.002)。
  • 未校正Cox回归中睡眠呼吸暂停预测MACCE(HR 1.69;95%CI 1.18–2.43),校正年龄、性别、体重指数、左心室射血分数、糖尿病、高血压、慢性肾脏病及日间过度嗜睡后仍显著(校正HR 1.57;95%CI 1.09–2.25)。

临床怎么用

  • 对拟行非急诊CABG的患者,可考虑术前筛查睡眠呼吸暂停以识别MACCE高风险人群。
  • 睡眠呼吸暂停(AHI≥15次/小时)可作为CABG术后不良心脑血管事件的独立风险标志。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with advanced coronary artery disease are referred for coronary artery bypass grafting (CABG) and it remains unknown if sleep apnoea is a risk marker. We evaluated the association between sleep apnoea and major adverse cardiac and cerebrovascular events (MACCE) in patients undergoing non-emergent CABG. METHODS: This was a prospective cohort study conducted between November 2013 and December 2018. Patients from four public hospitals referred to a tertiary cardiac centre for non-emergent CABG were recruited for an overnight sleep study using a wrist-worn Watch-PAT 200 device prior to CABG. RESULTS: Among the 1007 patients who completed the study, sleep apnoea (defined as apnoea-hypopnoea index ≥15 events per hour) was diagnosed in 513 patients (50.9%). Over a mean follow-up period of 2.1 years, 124 patients experienced the four-component MACCE (2-year cumulative incidence estimate, 11.3%). There was a total of 33 cardiac deaths (2.5%), 42 non-fatal myocardial infarctions (3.7%), 50 non-fatal strokes (4.9%) and 36 unplanned revascularisations (3.2%). The crude incidence of MACCE was higher in the sleep apnoea group than the non-sleep apnoea group (2-year estimate, 14.7% vs 7.8%; p=0.002). Sleep apnoea predicted the incidence of MACCE in unadjusted Cox regression analysis (HR 1.69; 95% CI 1.18 to 2.43), and remained statistically significant (adjusted HR 1.57; 95% CI 1.09 to 2.25), after adjustment for age, sex, body mass index, left ventricular ejection fraction, diabetes mellitus, hypertension, chronic kidney disease and excessive daytime sleepiness. CONCLUSION: Sleep apnoea is independently associated with increased MACCE in patients undergoing CABG. TRIAL REGISTRATION NUMBER: NCT02701504.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Koo CY, Aung AT, Chen Z, et al. Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting. Heart. 2020. PMID: 32423904. doi:10.1136/heartjnl-2019-316118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。